Literature DB >> 10548309

Dynamics of susceptibility and transmissibility of the live, attenuated, candidate vaccines dengue-1 PDK13, dengue-3 PGMK30F3, and dengue-4 PDK48 after oral infection in Aedes aegypti.

N Jirakanjanakit1, M M Khin, S Yoksan, N Bhamarapravati.   

Abstract

Dengue-1 virus PDK13 and isolates from vaccinees (dengue-1 Ib1 and dengue-1 Ib 10), dengue-3 PGMK30F3, and dengue-4 PDK48 were studied for their abilities to infect, disseminate, and replicate in Aedes aegypti mosquitoes by the oral route. In general, infection and dissemination rates were poorer for the vaccine compared with the parent viruses. The transmissibility was also lower for dengue-1 PDK13 than the parent virus, whereas it was not detected for isolates from vaccinees and dengue-3 PGMK30F3. Transmissibility of dengue-4 PDK48 was not determined because no dissemination occurred. Replication rates of vaccine strains were also found to be less efficient than the parent viruses. These imply that vaccination with the candidate vaccine is safe. Moreover, vector attenuation of vaccine viruses was consistent with its phenotypic markers of attenuation, which remained stable after a mosquito passage or after human and mosquito passage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548309     DOI: 10.4269/ajtmh.1999.61.672

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

1.  Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.

Authors:  Claire Y-H Huang; Siritorn Butrapet; Kiyotaka R Tsuchiya; Natth Bhamarapravati; Duane J Gubler; Richard M Kinney
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Authors:  C Y Huang; S Butrapet; D J Pierro; G J Chang; A R Hunt; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Limited Transmission Potential of Takeda's Tetravalent Dengue Vaccine Candidate by Aedes albopictus.

Authors:  Elizabeth A Dietrich; Yee Tsuey Ong; Janae L Stovall; Hansi Dean; Claire Y-H Huang
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

4.  American genotype structures decrease dengue virus output from human monocytes and dendritic cells.

Authors:  Raymond Cologna; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Stearoly-CoA desaturase 1 differentiates early and advanced dengue virus infections and determines virus particle infectivity.

Authors:  Rebekah C Gullberg; J Jordan Steel; Venugopal Pujari; Joel Rovnak; Dean C Crick; Rushika Perera
Journal:  PLoS Pathog       Date:  2018-08-17       Impact factor: 6.823

6.  Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).

Authors:  Claire Y-H Huang; Richard M Kinney; Jill A Livengood; Bethany Bolling; John J Arguello; Betty E Luy; Shawn J Silengo; Karen L Boroughs; Janae L Stovall; Akundi P Kalanidhi; Aaron C Brault; Jorge E Osorio; Dan T Stinchcomb
Journal:  PLoS Negl Trop Dis       Date:  2013-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.